Your browser doesn't support javascript.
loading
Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients.
Hernández-Boluda, Juan Carlos; Pereira, Arturo; Pastor-Galán, Irene; Alvarez-Larrán, Alberto; Savchuk, Alisa; Puerta, José Manuel; Sánchez-Pina, José María; Collado, Rosa; Díaz-González, Alvaro; Angona, Anna; Sagüés, Miguel; García-Gutiérrez, Valentín; Boqué, Concepción; Osorio, Santiago; Vallansot, Rolando; Palomera, Luis; Mendizábal, Arantxa; Casado, Luis Felipe; Pérez-Encinas, Manuel; Pérez-López, Raúl; Ferrer-Marín, Francisca; Sánchez-Guijo, Fermín; García, Carmen; Heras, Natalia de Las; López-Lorenzo, José Luis; Cervantes, Francisco; Steegmann, Juan Luis.
Afiliação
  • Hernández-Boluda JC; Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain. hernandez_jca@gva.es.
  • Pereira A; Hemotherapy and Hemostasis Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
  • Pastor-Galán I; Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain.
  • Alvarez-Larrán A; Hematology Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Savchuk A; Hematology Department, Hospital Universitario La Princesa, Madrid, Spain.
  • Puerta JM; Hematology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Sánchez-Pina JM; Hematology Department, Hospital 12 de Octubre, Madrid, Spain.
  • Collado R; Hematology Department, Hospital General Universitario, Valencia, Spain.
  • Díaz-González A; Hematology Department, Hospital La Fe, IIS La Fe, Valencia, Spain.
  • Angona A; Hematology Department, Hospital del Mar-IMIM, Barcelona, Spain.
  • Sagüés M; Hematology Department, Hospital Universitario de Girona, Doctor Josep Trueta, Girona, Spain.
  • García-Gutiérrez V; Hematology Department, Hospital Ramón y Cajal-IRYCIS, Madrid, Spain.
  • Boqué C; Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, Hospitalet de Llobregat, Spain.
  • Osorio S; Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Vallansot R; Hematology Department, Hospital Universitario Joan XXIII, Tarragona, Spain.
  • Palomera L; Hematology Department, Hospital Clínico Universitario Lozano Blesa, IIS Aragón, Zaragoza, Spain.
  • Mendizábal A; Hematology Department, Hospital Universitario de Álava, Vitoria, Spain.
  • Casado LF; Hematology Department, Hospital Virgen de la Salud, Toledo, Spain.
  • Pérez-Encinas M; Hematology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain.
  • Pérez-López R; Hematology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Ferrer-Marín F; Hematology and Medical Oncology Department, Hospital Morales Meseguer-CIBERER, IMIB-Arrixaca, UCAM, Murcia, Spain.
  • Sánchez-Guijo F; Hematology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.
  • García C; Hematology Department, Hospital General Universitario de Alicante, Alicante, Spain.
  • Heras NL; Hematology Department, Complejo Asistencial Universitario de León, León, Spain.
  • López-Lorenzo JL; Hematology Department, Fundación Jiménez Díaz, Madrid, Spain.
  • Cervantes F; Hematology Department, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Steegmann JL; Hematology Department, Hospital Universitario La Princesa, Madrid, Spain.
Blood Cancer J ; 8(10): 91, 2018 12 02.
Article em En | MEDLINE | ID: mdl-30504932
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Anticarcinógenos / Inibidores de Proteínas Quinases Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Anticarcinógenos / Inibidores de Proteínas Quinases Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha